14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.10 $18.06 Friday, 3rd May 2024 RCUS stock ended at $15.70. This is 1.29% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.62% from a day low at $15.49 to a day high of $16.36.
90 days $14.10 $20.30
52 weeks $12.96 $25.47

Historical Arcus Biosciences Inc. prices

Date Open High Low Close Volume
May 03, 2024 $15.97 $16.36 $15.49 $15.70 519 624
May 02, 2024 $15.70 $15.80 $15.31 $15.50 442 138
May 01, 2024 $15.27 $16.38 $15.13 $15.50 375 297
Apr 30, 2024 $15.38 $15.69 $15.14 $15.23 523 590
Apr 29, 2024 $15.32 $15.93 $15.20 $15.63 611 490
Apr 26, 2024 $14.73 $15.62 $14.59 $15.55 494 575
Apr 25, 2024 $15.19 $15.19 $14.65 $14.73 454 575
Apr 24, 2024 $15.49 $15.85 $14.71 $15.43 506 853
Apr 23, 2024 $14.77 $15.62 $14.57 $15.50 582 461
Apr 22, 2024 $14.67 $15.19 $14.51 $14.68 443 094
Apr 19, 2024 $14.77 $15.19 $14.10 $14.59 440 664
Apr 18, 2024 $14.74 $14.94 $14.51 $14.84 807 678
Apr 17, 2024 $15.95 $16.04 $14.79 $14.84 765 813
Apr 16, 2024 $16.32 $16.62 $15.85 $15.87 308 117
Apr 15, 2024 $16.56 $16.66 $16.03 $16.29 315 264
Apr 12, 2024 $17.21 $17.50 $16.17 $16.58 468 621
Apr 11, 2024 $16.92 $17.37 $16.66 $17.29 347 483
Apr 10, 2024 $16.91 $17.12 $16.50 $16.73 491 178
Apr 09, 2024 $17.04 $17.64 $16.83 $17.45 321 898
Apr 08, 2024 $17.41 $17.56 $16.69 $16.97 277 692
Apr 05, 2024 $17.08 $17.35 $16.61 $17.34 496 895
Apr 04, 2024 $17.80 $18.06 $17.21 $17.27 563 661
Apr 03, 2024 $17.62 $17.84 $17.00 $17.69 340 162
Apr 02, 2024 $18.03 $18.27 $17.57 $17.72 392 534
Apr 01, 2024 $18.78 $18.85 $18.22 $18.48 498 149
Click to get the best stock tips daily for free!

About Arcus Biosciences Inc.

Arcus Biosciences. Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha... RCUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT